Qube Research & Technologies LTD Vbi Vaccines Inc Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.38 - $22.5 $6,144 - $363,847	-16,171 Reduced 52.05%	14,899 $5,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $327,630 - $10.5 Million	-448,809 Reduced 93.53%	31,070 $22,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $258,049 - $707,681	390,984 Added 439.83%	479,879 $388,000
Q1 2022 May 09, 2022	BUY	$1.27 - $2.47 $23,495 - $45,695	18,500 Added 26.28%	88,895 $148,000
Q4 2021 Feb 01, 2022	BUY	$2.21 - $3.22 $90,528 - $131,900	40,963 Added 139.18%	70,395 $165,000
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $129,161 - $171,599	-46,129 Reduced 61.05%	29,432 $92,000
Q2 2021 Aug 13, 2021	BUY	$2.61 - $4.17 $197,214 - $315,089	75,561 New	75,561 $253,000
Q4 2020 Feb 16, 2021	SELL	$2.15 - $3.5 $241,576 - $393,263	-112,361 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$2.77 - $6.17 $311,239 - $693,267	112,361 New	112,361 $321,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.